Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Home Newsletters

New York Real Estate Law Reporter

December 2025
Search Archives › SUBSCRIBE

Features

The Uniform Partition of Heirs Property Act After 'Laurelton' Image

The Uniform Partition of Heirs Property Act After 'Laurelton'

Christopher Ryan Clarke

In 2019, the Uniform Partition of Heirs Property Act/RPAPL §993 (the UPHPA) reshaped the rights of co-owners of inherited property in New York, replacing the traditional, sale-favoring partition system with a multi-layered process designed to limit the right to seek partition and to prioritize family ownership. The Second Department’s sweeping decision confirms that the partition landscape has drastically changed.

Columns & Departments

Real Property Law Image

Real Property Law

New York Real Estate Law Reporter Staff

Survey Insufficient to Establish BoundaryAdverse Possession Claim Defeated for Failure to Establish Reasonable Basis for Belief of OwnershipServient Owner Prohibited from Locking Gate Over EasementShining Lights Over Neighboring Property Raises Questions of Fact About Nuisance ClaimPractical Location of Boundaries Doctrine AppliedWhen Court-Ordered License Expires, Licensor Is Entitled to Use and Occupancy

Columns & Departments

Development Image

Development

New York Real Estate Law Reporter Staff

Special Permit Denial OverturnedNo Property Right to Short-Term RentalsZBA Interpretation of Zoning Ordinance Upheld

Columns & Departments

Co-ops and Condominiums Image

Co-ops and Condominiums

New York Real Estate Law Reporter Staff

Co-Op Board Not an Entity Amenable to Suit

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›